NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Side effects of antimotion sickness drugsThe effects on operational proficiency of the antimotion sickness drugs scopolamine, promethazine and d-amphetamine are tested using a computerized pursuit meter. Proficiency is not significantly affected by oral doses of 0.25 mg or 0.50 mg scopolamine but is descreased by oral or I.M. doses of 25 mg promethazine. The performance decrement associated with 25 mg oral promethazine is prevented when combined with 10 mg oral d-amphetamine. The combination of 25 mg I.M. promethazine, 25 mg oral promethazine and 10 mg d-amphetamine produces less performance decrement than oral or I.M. doses of promethazine alone, though more performance decrement than a placebo. I.M. promethazine is adsorbed slowly and consequently may provoke drowsiness.
Document ID
19840038950
Acquisition Source
Legacy CDMS
Document Type
Reprint (Version printed in journal)
Authors
Wood, C. D.
(Louisiana State Univ. Shreveport, LA, United States)
Manno, J. E.
(Louisiana State Univ. Shreveport, LA, United States)
Manno, B. R.
(Louisiana State Univ. Shreveport, LA, United States)
Redetzki, H. M.
(Louisiana State Univ. Shreveport, LA, United States)
Wood, M. D.
(Louisiana State Univ. Shreveport, LA, United States)
Vekovius, W. A.
(Louisiana State University, Shreveport, LA, United States)
Date Acquired
August 12, 2013
Publication Date
February 1, 1984
Publication Information
Publication: Aviation, Space, and Environmental Medicine
Volume: 55
ISSN: 0095-0562
Subject Category
Aerospace Medicine
Accession Number
84A21737
Funding Number(s)
CONTRACT_GRANT: NAS9-16801
Distribution Limits
Public
Copyright
Other

Available Downloads

There are no available downloads for this record.
No Preview Available